An international team of scientists developed a new blood-testing method to detect earlier and more accurately if diabetic patients had developed life-threatening complications like heart disease and kidney failure.
The paper’s co-corresponding author, Zhang Wei, associate professor of cancer epidemiology and prevention at Northwestern University, said.
The study published in the journal, Clinical Chemistry, described the revolutionary new technology that used just a few drops of blood for testing.
“This discovery is going to revolutionise how quickly and non-invasively we can identify potentially fatal complications in the hundreds of millions of diabetic patients worldwide,” Wei said.
It is the latest discovery in the new blood-testing technology that Northwestern scientists used most recently to detect liver cancer in patients and is now being tested in other major cancers.
About two-thirds of the 424 million diabetic patients worldwide die from vascular complications, and detecting these complications early could enable treatments to control the development of severe disease or death, according to the researchers.
However, current methods of diagnosis, including analysing a patient’s body mass index, the length of time they have had diabetes or a blood test analysing how much waste product is present are prone to error and don’t identify complications early enough.